Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Coverage CARotid Stenting vs. Medical Management Alone to Prevent EmboliSm From symptomaTic Non-stenotic cARotid Disease (SyNC) - CARESTAR

NCT07166731 is registered in ClinicalTrials.gov with Acandis GmbH as lead sponsor.

NCT NCT07166731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07166731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Coverage CARotid Stenting vs. Medical Management Alone to Prevent EmboliSm From symptomaTic Non-stenotic cARotid Disease (SyNC) - CARESTAR
Lead sponsor
Acandis GmbH
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2026
Completion date
June 30, 2032
Enrollment
536 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carotid artery disease, carotid artery stenting, carotid artery thrombosis, carotid plaque imaging, embolic stroke of undetermined source, symptomatic carotid artery stenosis